Shenzhen Enrich Electronics Co., Ltd

Favorite  |  Set Home
skype: cassie_1191
QQ: 2850818618
FACEBOOK: Cassie Huang
E-mail: 黄露
Company News >> Sharp OLED panels aim at the first external sales of the medical market 7th,Dec,2021
                                            It has been two years since the start of production in 2018, and Sharp announced for the first time to sell OLED panels, which is surprisingly in the smart medical market. The ultra-high-brightness OLED module developed by Sharp this time will be used by the Japanese medical manufacturer Finex on the Gaze Analysing Perimeter (Gaze Analysing Perimeter).

Sharp has achieved ultra-high brightness through fine-tuning current control and other technologies, reaching more than 3,000 cd/㎡, which is 3 to 5 times the brightness of ordinary consumer products. In addition, Sharp also collaborated with FINDEX and EMC Healthcare, a subsidiary of FINDEX, to develop a chip that can view grayscale characteristics to achieve the best display for different brightness.

After the introduction of this module into the visual inspection instrument of medical institutions, it is expected that diseases such as glaucoma and retinal detachment can be detected and treated as soon as possible.

RUNTO believes that at a time when Apple cannot start supplying OLEDs, the future of Japanese manufacturers with high personnel management costs such as Sharp is to continue to develop distinctive OLED modules for use in medical, automotive and other applications. The high value-added niche market achieves more innovation and establishes the barriers for other manufacturers to enter this market. At the same time, in the dedicated or commercial market, solving the reliability and lifetime of OLEDs is also the most basic issue.

Currently, the smart medical market has a huge space, especially the medical imaging market in equipment. According to the RUNTO Smart Medical Report, China's medical imaging market is expected to reach US$18 billion in 2020, accounting for 20% of the global medical imaging market; from 2010 to 2020, the compound growth rate of China's medical imaging market will reach 14. 4%. 2010-2020 China's medical imaging industry market size

Data source: RUNTO, unit: US$100 million

Further reading Japanese medical brand Finex has been conducting research and development of new ophthalmic diagnostic technology since 2017, mainly for ophthalmological diseases that are difficult to detect in the early stage of glaucoma, and can cause vision and even irreparable damage in severe cases. This kind of disease has been necessary in the past. With complex ophthalmological equipment diagnosis, considering that most people will not go to the ophthalmology hospital for examination, almost all patients see the doctor only after they are serious, and the opportunity is missed.

The technology to solve the problem that is difficult to diagnose early is the gaze tracking technology for the development of wearable technology. Finex puts forward the concept of GAP for this purpose. The display device can be used with gaze tracking technology and AI to determine whether the patient’s eye has early signs of glaucoma. It can also be used to diagnose retinal detachment, even Alzheimer's disease and other diseases that can be judged in advance from the visual response.

Online service

Skype: cassie_1191 2850818618